D. Markovitz - Engineering a therapeutic Lectin: uncoupling mitogenicity from antiviral activity
Infectious Diseases ›47:24 | Sep 3rd, 2016
David Markovitz, Department of Internal Medicine, University of Michigan, Michigan, MI, USA speaks on "Engineering a therapeutic Lectin: uncoupling mitogenicity from antiviral activity". This seminar ...Show More
Recommendations